About the Journal
Journal of Oncology Research and Therapy an esteemed open-access publication dedicated to ensure that crucial research reaches a global audience, fostering collaboration and innovation among researchers, clinicians, and healthcare professionals.
Scope:
Journal covers broad spectrum of topics in the field medical, surgical, and radiation oncology, along with clinical oncology.
Including but not limited to
Diagnostic Advances: Within the realm of diagnostic advances, "Journal of Oncology Research and Therapy" (JONT) delves into the multifaceted landscape of cancer diagnosis. We explore an array of methodologies, from the precision of biopsy and the insight of endoscopy to the intricate imaging techniques.
Therapeutic Innovations: In the realm of therapeutic innovations, JONT aims to publish the latest advancements in cancer treatment modalities. From traditional approaches such as surgery and chemotherapy to cutting-edge techniques like radiotherapy and immunotherapy, we delve into the diverse arsenal of treatments available. Moreover, we explore the transformative potential of personalized medicine, driven by genetic and molecular markers, in revolutionizing cancer care.
Palliative Care: In acknowledging the pivotal role of palliative care, Journal of Oncology Research & Therapy serves for disseminating studies focused on enhancing patient well-being and managing symptoms in advanced cancer. Recognizing the significance of quality of life, our publication is committed to spotlighting research that advances the understanding and delivery of palliative care in oncology.
Read More At Aims and Scope Page
Editorial Team:
Our esteemed editorial team comprises leading experts and researchers in the field of oncology. They bring a wealth of experience and a commitment to maintaining the highest standards of scientific integrity. The rigorous peer-review process ensures that published articles meet these standards and contribute meaningfully to the field.
Publication Frequency:
The Journal is published quarterly, with four issues released annually. This regular schedule ensures a steady flow of the latest research findings and developments in the field of oncology, allowing our readers to stay abreast of cutting-edge advancements throughout the year.
Abstracting and Indexing:
- Each publication is assigned with Digital Object Identifier (DOI) number – Crossref.
- Scilit
- ResearchGate
- Google Scholar
- ScienceGate
- Semantic Scholars
- ACADEMIA
- Dimensions AI
- FatCat Wiki
- Internet Archive Scholar
- Directory of Open Access Scholarly Resources
- CrossRef
- Genamics - JournalSeek
- Academic Keys
- ResearchBib - Academic Research Index
- Geneva Foundation for Medical Education and Research
- International Innovative Journal Impact Factor (IIJIF)
- Open J-Gate
- Directory of Journals indexing
- Scopus Impact Factor
- NIH funded articles in the field will be assigned for PubMed inclusion
Why Choose Journal
- High Quality Articles Published.
- High Impact Factor Journal.
- Indexing and Abstracting in Major Databases
- We maintain high standard peer review publications.
- We ensure optimum quality standard is maintained in every publication.
- Increased visibility of the publication and provides free, unrestricted global access.
- We provide higher readership, visibility and impact of your publications, we have dedicated marketing team to reach your work to broad audience.
- The authors reserve the copyrights of the article and articles are published under a Creative Commons Attribution License.
Submit Your Manuscript:
We invite researchers, clinicians, and scientists to submit their original contributions to the Journal of Oncology Research and Therapy. Our platform provides a unique opportunity to share your work with the global oncology community and contribute to the collective knowledge in the fight against cancer.
Welcome to the Manuscript Submission Page
Ready to submit your manuscript for review? Simply click the link below to start the process. It's quick, easy, and secure!
Submit Your Manuscript NowNeed help? Contact Support
Editorial Board
Recently Published Articles
Severe COVID-19 Among Cutaneous Melanoma Patients with COVID Seen in US Oncology Offices
Leslie K. Dennis, Amanda K. Arrington
Exercise Treatment for Cancer-Related Pain
Mizuho Sumitania, Yuko Otakec, Michihiro Osumid, Reo Inouee, Rikuhei Tsuchidae, Takamichi Kogureb, Hiroaki Abeb, Soko Aokig, Masahiko Sumitanib
Long-Course Chemoradiotherapy (LCRT) Shows Better Outcomes than Short-Course Chemoradiotherapy (SCRT) in Locally Advanced Rectal Cancer (LARC): Insigh
Giddi Maurya Krishna, Sushma Agrawal, Neeraj Rastogi, Shalini Singh, Ashok Kumar, Rajneesh Singh, Ashish Singh, Rahul Rahul, Prabhakar Mishra
Gastrointestinal Toxicities of Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients. A Review
Fausto Meriggi, Sara Cherri, Diego Gavezzoli, Fabio Pirracchio, Tony Sabatini, Claudio Bna’, Giordano Savelli, Alberto Zaniboni
In Vitro Oncogenic Effects of Glycated Albumin in Human Colorectal Cancer Cell lines HT29 and SW620 Revealing EpCAM and Galectin-3 Upregulation in T
Yahya Maashi, Shaykhah Almutairi, Maram Aldawood, Hamad Al-Eidi, Rehab AlRoshody, Hind A Alghamdi, Sara Bahattab, Abdulmonem A Alsaleh, Haitham Alkadi, Saleh Alghamdi, Bader Almuzzaini, Sabine Matou-Nasri,
Effectiveness of A Reusable, Self-Contained Cryotherapy Delivery Device on Mitigating the Use and Intensity of Analgesics in Patients Being Treated wi
Vikas Dembla, Katherine Corbett, Rosemarie Velasquez, Kristen Wilson, Indrea Jackson, Richard Zuniga, Frank Jacobucci, Stephen Sonis,
Circulating Cell-Free miR-154-5p in Plasma as A Non-Invasive Biomarker for Liquid Biopsy to Predict Survival in Oral Squamous Cell Carcinoma Patients
Adhikary P, Das S, Naskar D, Pal P, Bararia A, Das S, Karanjai S, Daga D, Singh V, Saha A, Neguive Z, Dutta A, Banerjee N, Naikoo NN, Jain P, Manikantan K, Arun P, Mukhopadhyay S, Ghosh RD
Antiproliferative and Antimigratory Effects of mTOR Inhibitors in Paediatric Low-grade Gliomas Models. A Comparison between Rapamycin and Sapaniserti
Pizzoferrato M, Ferraro C, Graziano M, Ciotti GMP, Ruggiero A, Navarra P, Lisi L
3D Specimen Tomosynthesis Real-Time Assessment by Radiologists and Surgeons Potentially Decreases the Margin Re-excision Rate Following Breast-Conser
Attia M, Badawy K, SinhaA, Jeffery H, Garg Y, Shifa B, Manning R, Karthigan R, Kothari A
The Correlation of Magee Equations and Oncotype DX Recurrence Score in Mexican Patients Diagnosed with Early Breast Cancer
Maffuz-Aziz A, Monges-Jones JE, Guerrero GEA, Nehmad-Misri C